Advent International to Acquire Significant Stake in Suven Pharmaceuticals
December 26, 2022
Advent International has entered into a definitive agreement to acquire a significant stake in Suven Pharmaceuticals from the Jasti family and will make an open offer for an additional 26% of public shares. Advent plans to evaluate a merger of its CDMO and API platform company, Cohance Lifesciences, with Suven to create a scaled end-to-end CDMO + merchant API powerhouse serving pharma and specialty chemical markets, subject to board and regulatory approvals.
- Buyers
- Advent International
- Targets
- Suven Pharmaceuticals
- Sellers
- Jasti family
- Platforms
- Cohance Lifesciences
- Industry
- Pharmaceuticals
- Location
- Telangana, India
- Transaction Type
- Buyout
Explore More
Related Acquisitions
-
Advent International Proposes Going-Private Acquisition of Definitive Healthcare
September 2, 2026
Data & Analytics
Boston-based Advent International has proposed taking Definitive Healthcare private through an all-cash offer for all outstanding shares of Definitive’s Class A stock and interests in its operating entity. The proposal is nonbinding, and Definitive has formed a special committee of independent directors to evaluate it.
-
Natura Acquires Stake by Advent International (8%–10% Minority Investment)
March 31, 2026
Consumer Products
Brazilian cosmetics company Natura announced a governance overhaul and a minority investment from Advent International. Advent will acquire an 8%–10% stake by purchasing shares over time (expected over up to six months) and will have the right to appoint two board members once the stake is reached.
-
Advent International Acquires Majority Stake in SYSPRO
August 13, 2024
Software
Advent International has entered into a definitive agreement to acquire a majority ownership stake in SYSPRO, a global ERP software provider for manufacturing and distribution. The investment will fund product and technology innovation and support SYSPRO's global growth ambitions, particularly in the USA and UK; the deal is expected to close in late Q3 2024 pending customary approvals.
-
Advent International to Acquire Significant Stake in Imperial Dade from Bain Capital Private Equity
May 2, 2022
Industrial Services
Advent International has signed a definitive agreement to acquire a significant stake in Imperial Dade, a leading North American distributor of food service packaging and janitorial supplies, from Bain Capital Private Equity. The deal involves joint board governance, while Robert and Jason Tillis continue to lead the business and remain significant investors.
-
Advent International Makes Strategic Growth Investment in Iodine Software
December 1, 2021
AI & Machine Learning
Advent International agreed to acquire a significant stake in Iodine Software in a strategic growth investment that values the company at over $1 billion. The capital will support Iodine's expansion of its AI-powered clinical documentation and revenue-cycle products (CognitiveML) and help scale its go-to-market reach across hospitals and health systems.
-
Advent International and Cinven Acquire thyssenkrupp Elevator from thyssenkrupp AG
July 31, 2020
Manufacturing
Advent International and Cinven have completed the acquisition of thyssenkrupp's Elevator Technology business (thyssenkrupp Elevator) from thyssenkrupp AG, with thyssenkrupp AG retaining a substantial minority stake. The global elevator and escalator manufacturer and service provider is headquartered in Germany and will pursue growth through geographic expansion, strategic acquisitions, and investment in R&D backed by the Consortium's financial resources.
Build a buyer list for your deal
Find active buyers from recent acquisition patterns and move straight into outreach.